Suspended National Police Commissioner General Fannie Masemola. His suspension has sent shockwaves through South Africa’s law enforcement establishment.
Image: Kopano Tlape | GCIS
THE suspension of Fannie Masemola has sent shockwaves through South Africa’s law enforcement establishment. But beyond the headlines, the case offers a deeper and more uncomfortable lesson: procurement fraud is not an anomaly; it is a systemic risk that can reach the highest levels of any organisation.
For leaders in risk, compliance, and governance, the real question is not whether fraud exists, but whether the right safeguards are in place to detect and prevent it.
According to Servaas du Plessis, chief executive at XTND, a specialist in white-collar crime prediction and detection, one of the most troubling aspects of procurement fraud is how visible the warning signs often are — if anyone is willing to look.
Masemola faces allegations of violating the Public Finance Management Act (PFMA) in connection with a R360 million healthcare contract awarded to Medicare24, a company reportedly linked to organised crime. Around R50m had already been paid out before the contract was halted.
This is more than a political scandal. It is, as Du Plessis describes it, a textbook case of procurement failure.
Procurement fraud tends to follow a predictable pattern. An insider with decision-making authority collaborates with an external party to manipulate the tender process. Contracts are steered toward preferred vendors, often at inflated prices, and payments begin flowing long before proper scrutiny takes place. By the time irregularities are detected, substantial funds have already been lost.
The alleged collusion in the Medicare24 case fits this pattern almost perfectly. While the contract was ultimately cancelled, tens of millions of rand had already been disbursed.
Crucially, this is not a problem confined to government. The same vulnerabilities exist in private-sector organisations across industries — from construction and healthcare to IT and professional services. Wherever large contracts are awarded, the opportunity for manipulation follows.
What makes cases like this particularly frustrating is that the red flags are rarely sophisticated. In fact, Du Plessis says that they are often basic indicators that should trigger scrutiny.
Vendor risk is one of the first. Was Medicare24 subjected to proper due diligence before being awarded such a large contract? Were its ownership structures, leadership, and potential links to politically exposed persons thoroughly examined?
Procurement irregularities are another. Were standard tender processes followed? Was there genuine competition, or were specifications designed to favour a particular bidder? Were evaluation committees independent and free of conflicts?
Payment patterns also matter. The release of R50m before the contract’s cancellation raises critical questions. Were payments linked to verified deliverables, or were controls bypassed?
Finally, insider behaviour often provides clues. Sudden lifestyle changes, unexplained wealth, or unusual decision-making patterns among officials involved in procurement should never be ignored.
As Du Plessis notes, these are not advanced forensic techniques — they are fundamental controls that every organisation should already have in place.
What elevates the Masemola case from a single scandal to a broader warning is its systemic nature. This is not an isolated breakdown but part of a pattern of governance failures.
Recent reports of misappropriated funds at the National Lotteries Commission (NLC) and a questionable multibillion-rand textbook tender highlight a recurring issue: When misconduct reaches the top, it signals that controls have failed at every level.
“It is here where governance structures weaken and oversight becomes ineffective or compromised. A culture of impunity begins to take hold, and this dynamic is not limited to the public sector,” Du Plessis warns.
In private organisations, leadership behaviour sets the tone. When executives prioritise results over process, tolerate conflicts of interest, or encourage “getting deals done” at any cost, those signals cascade through the organisation. Middle managers learn that compliance is optional and procurement officials stop asking difficult questions, and fraudsters recognise opportunity.
Du Plessis says that scandals like these should trigger reflection at the highest levels. Boards, audit committees, and executives should be asking a simple but critical question: Could this happen here?
Addressing procurement risk requires more than policy; it requires disciplined execution.
There is often resistance to enhanced controls, with arguments that due diligence and compliance measures are costly or time-consuming. But the alternative is far more expensive.
In the Medicare24 case alone, R50m was lost before intervention. That figure excludes legal costs, reputational damage, operational disruption, and the diversion of resources to crisis management.
Beyond financial losses, there is a deeper cost: The erosion of trust. For governments, this translates into declining public confidence and political consequences. For businesses, it impacts customers, investors, and long-term sustainability.
Prevention, as Du Plessis emphasises, is always cheaper than cure.
The Masemola scandal is not just about one individual or one contract. It is a case study in how fraud takes root, spreads, and ultimately exposes organisational weaknesses.
The lesson is clear: Procurement integrity is not a compliance exercise, it is a leadership responsibility.
* Content supplied by XTND is a South African-owned forensic investigations company specialising in the prevention, detection, and response to white-collar crime and corruption.
** The views expressed here do not reflect those of the Sunday Independent, IOL, or Independent Media.